GO
Loading...

Johnson & Johnson

More

  • FACTBOX-M&A frenzy transforming global pharma Monday, 14 Jul 2014 | 9:27 AM ET

    July 14- Several multi-billion dollar deals and bids have made 2014 a busy year for healthcare acquisitions, despite Pfizer pulling its $118 billion offer for AstraZeneca.

  • Will earnings tell the story markets need to hear? Sunday, 13 Jul 2014 | 6:21 PM ET
    Traders work the floor of the New York Stock Exchange before the closing bell in New York.

    Quarterly earnings growth and clues from companies' commentaries will tell whether there really will be a bounce back in growth in the second half.

  • July 11- Big Pharma companies are trying to offload low-growth, mature drug portfolios to firms such as Blackstone Group LP and TPG Capital LP which need to figure out how to carve them out, in one of private equity's greatest dealmaking challenges.

  • The Alzheimer's epidemic: Where we stand Friday, 11 Jul 2014 | 11:45 AM ET

    Although treatments for Alzheimer's have struggled, drugmakers are still working in the space, with 67 medicines currently in development.

  • For the larger companies, the initiative ensures that their own suppliers are robust and "demonstrates a recognition that a healthy supply chain is good for business," the White House said in a statement.

  • High-tech way to apply sunscreen Wednesday, 9 Jul 2014 | 3:32 PM ET
    SnappyScreen applies sunscreen over entire body in 10 seconds

    SnappyScreen founder Kristen McClellan says she has a better, faster way to apply sunscreen. Will the Power Pitch panel agree?

  • *France's Servier, Israel's Teva among those fined. BRUSSELS, July 9- European Union antitrust regulators fined French drugmaker Servier, Israel's Teva and four others a total of 428 million euros on Wednesday, as they crack down on deals which block cheaper generic medicine.

  • *Sodexo cuts 2013/ 14 sales growth goal to 2.2-2.5 pct. *Sodexo keeps full-year profit goals. PARIS, July 9- Sodexo, the world's second-biggest catering services company, cut it full-year sales growth forecast on Wednesday, warning its fourth quarter would be weaker than expected due to the delayed start-up of some large contracts.

  • In preparatory documents posted on the agency's website on Tuesday, FDA reviewers said laparoscopic power morcellator devices, which are used to treat uterine fibroids, allow for less invasive surgeries, shorter recovery time and fewer wound site infections.

  • LONDON, July 6- The drugs don't work- and neither does the market, when it comes to antibiotics. Totally resistant forms of the lung infection emerged in India just a few years ago and have now been detected worldwide.

  • INSIGHT-How to fix a broken market in antibiotics Sunday, 6 Jul 2014 | 4:59 AM ET

    LONDON, July 6- The drugs don't work- and neither does the market, when it comes to antibiotics. Totally resistant forms of the lung infection emerged in India just a few years ago and have now been detected worldwide.

  • Laggardly Dow crosses 17,000 milestone Thursday, 3 Jul 2014 | 12:09 PM ET

    NEW YORK, July 3- Wall Street on Thursday celebrated its love of zeros- the ones that come after commas, that is- as the Dow Jones Industrial Average topped the 17,000 mark for the first time.

  • *Roche adds to breast cancer drug offering with Seragon. Roche is looking to bolster its offering of breast cancer drugs with the purchase. Since walking away from a $6.8 billion deal to buy U.S gene sequencing company Illumina in 2012 Roche has eschewed multi-billion deals and instead snapped up a couple of smaller diagnostic companies so far this year.

  • Finally! Shining the light on dark pools Tuesday, 1 Jul 2014 | 1:03 PM ET

    The SEC is shining a bright light on dark pools. Are we finally ending this cycle of bad market behavior?, asks NYSE floor trader Kenny Polcari.

  • FRANKFURT, July 1- German drugmaker Bayer said it would keep the Dr. Scholl's and Coppertone- each worth more than $1 billion- Bayer said it was not planning to untie the Merck bundle it secured in May in a competitive bidding tussle with Reckitt Benckiser, Procter& Gamble Co and Novartis.

  • FRANKFURT, July 1- German drugmaker Bayer said it would keep the Dr. Scholl's and Coppertone- each worth more than $1 billion- Bayer said it was not planning to untie the Merck bundle it secured in May in a competitive bidding tussle with Reckitt Benckiser, Procter& Gamble Co and Novartis.

  • Second half playbook: Pros hunt for value Monday, 30 Jun 2014 | 4:16 PM ET
    Trader on the floor of the New York Stock Exchange.

    Investors are placing bets on how the second half of 2014 will unfold. Here are their picks.

  • FDA warning: Popular acne products cause reactions Wednesday, 25 Jun 2014 | 2:09 PM ET

    The U.S. Food and Drug Administration warned that popular acne products can cause rare but serious and life-threatening allergic reactions.

  • WASHINGTON, June 23- President Barack Obama met with Goldman Sachs Chief Executive Lloyd Blankfein, Johnson& Johnson chief Alex Gorsky and other business leaders on Monday to discuss ways to encourage companies to make their work places more family friendly.

  • WASHINGTON, June 23- President Barack Obama on Monday directed the federal government to give workers more leeway in determining their schedules, part of his goal to make U.S. workplaces more family-friendly- and a broad pitch to Democratic voters ahead of November elections.